Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on ‘Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis’ by Jonssonet al

MLA

Maxime Chevreau, et al. “Calprotectin Is Not Independent from Baseline Erosion in Predicting Radiological Progression in Early Rheumatoid Arthritis. Comment on ‘Calprotectin as a Marker of Inflammation in Patients with Early Rheumatoid Arthritis’ by Jonssonet Al.” Annals of the Rheumatic Diseases, vol. 77, Jan. 2018, p. e84. EBSCOhost, https://doi.org/10.1136/annrheumdis-2017-212816.

APA

Maxime Chevreau, Olivier Vittecoq, Xavier Romand, Marie-Hélène Paclet, Philippe Dieudé, Jean-Louis Quesada, Bertrand Toussaint, Philippe Gaudin, & Athan Baillet. (2018). Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis. Comment on ‘Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis’ by Jonssonet al. Annals of the Rheumatic Diseases, 77, e84. https://doi.org/10.1136/annrheumdis-2017-212816

Chicago

Maxime Chevreau, Olivier Vittecoq, Xavier Romand, Marie-Hélène Paclet, Philippe Dieudé, Jean-Louis Quesada, Bertrand Toussaint, Philippe Gaudin, and Athan Baillet. 2018. “Calprotectin Is Not Independent from Baseline Erosion in Predicting Radiological Progression in Early Rheumatoid Arthritis. Comment on ‘Calprotectin as a Marker of Inflammation in Patients with Early Rheumatoid Arthritis’ by Jonssonet Al.” Annals of the Rheumatic Diseases 77 (January): e84. doi:10.1136/annrheumdis-2017-212816.